Democrats eyeing higher office and seeking street cred in the debate are devising more innovative and aggressive strategies to take on Big Pharma.

The suit alleged Walgreens improperly billed federal health care programs for unnecessary insulin pens.

Concerned by the lack of competition in the U.S. generic market, Sen. Elizabeth Warren has proposed creating a new drug manufacturing department.

Small-scale, practical uses of data that can improve individual patients' well-being and support healthier workforces more broadly.